Urology Care Devices and Platforms Market Size, Share & Trends Analysis Report By Products (Devices, Platforms), By Applications (Treatment, Diagnosis and Monitoring), By Indication (Kidney Diseases, Urological Cancer and Benign Prostatic Hyperplasia, Pelvic Organ Prolapse, Other Diseases), By End-User (Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, Homecare Settings) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Urology Care Devices and Platforms Market Size

The global urology care devices and platforms market size was valued at USD 45.57 billion in 2025 and is projected to grow from USD 49.64 billion in 2026 to USD 98.40 billion by 2034, registering a CAGR of 8.93% during the forecast period from 2026 to 2034. North America dominated the urology care devices and platforms market with a market share of 38.4% in 2025.

The American Urological Society describes urology as the medical and physiological field that "deals with illnesses of the male and female urinary system" (kidneys, ureters, bladder, and urethra). The male reproductive organs (penis, testicles, scrotum, prostate, etc.) are also covered. Problems with one of the urinary or reproductive tracts frequently affect the other because of their interdependence. Thus, genitourinary disorders cover a wide range of conditions treated in urology. Urologists are medical specialists focusing on the urology sector who are educated to identify, diagnose, and treat this group of problems and diseases.

The term "urology devices" refers to the medical equipment used to diagnose a wide range of conditions affecting the urinary tract. These devices aid in treating kidney stones, prostate enlargement, bladder cancer, and prostate cancer. Urology devices can shorten patients' treatment and recovery times more effectively. Platforms in the global urology care devices and platforms market mobile applications or software that focus on improved imaging analytics, data analytics, and remote patient monitoring.

Products Insights

The devices segment owns the highest market share and is expected to exhibit a CAGR of 8.84% during the forecast period. Urological medical devices are indicated to diagnose, treat and manage urological conditions such as urinary incontinence, kidney stones, benign prostatic hyperplasia (BPH), and urologic cancers. The urologic devices can be segmented into conventional and advanced devices based on the degree of technology integration. Devices such as dialysis devices, endoscopy and imaging devices, lasers and lithotripsy devices, endoscopy fluid management, insufflators, and urodynamic devices are conventional, whereas neurostimulators and robotic systems are advanced.

Request Customizationto receive a tailored report.

Application Insights

The treatment segment dominates the global market and is projected to exhibit a CAGR of 8.94% over the forecast period. Many conventional and advanced devices are used to treat these urological disorders. The treatment segment of the global urological care devices and platforms market is projected to hold a larger market share throughout the forecast period. The rise in urological disorder prevalence and healthcare expenditure drive the segment's growth. However, the need for reimbursement coverage and the high cost of treatment are anticipated to restrain segment growth. Companies operating in this segment include Albyn Medical Ltd., Axonics Modulation Technologies, Inc., BlueWind Medical, Boston Scientific Corporation, innoMedicus Ltd., and Medtronic plc.

Indication Insights

The kidney diseases segment is responsible for the largest market share and is estimated to exhibit a CAGR of 8.48% over the forecast period. Kidney stones are among the most common urological disorders affecting the kidneys. Kidney stones are examined using a ureteroscope and further treated using technologies such as laser ablation therapy. Either continuous or pulsed energy from a laser breaks up the stones into fragments, which are subsequently collected using a stone basket and drained from the body. Companies offering products for treating and diagnosing kidney diseases include Dornier MedTech Gmbh, Asclepion Laser Technologies GmbH, Boston Scientific Corporation, and KARL STORZ SE & Co. KG, among others. Furthermore, an increase in the prevalence of kidney diseases, a rise in the diabetic population, and increasing healthcare expenditure are factors driving the segment's growth. However, high treatment costs are anticipated to restrain segment growth.

End-User Insights

The hospitals, ASCs, and clinics segment owns the highest market share and is anticipated to exhibit a CAGR of 8.58% over the forecast period. Many urological procedures, such as endoscopies, biopsies, lithotripsies, and implantation of medical devices for urinary incontinence, are conducted in hospital settings. This is due to the need for postoperative care of the patients. The rise in the patient population requiring urological surgeries, facilities for postoperative care, and rising hospital expenditure are factors driving the hospital segment.

Clinics are smaller service centers than hospitals, with comparatively fewer beds and services. While clinics offer the facilities and equipment required for diagnosis and treatment, they also provide a more personalized work environment and allow for building better patient-physician relationships. Further, ASCs are healthcare settings committed to providing patients with diagnostic and treatment care on the same day. Technological advancements have helped reduce instances of patient overnight stays and faster recovery, allowing for more procedures to be effectively conducted at ASCs.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global market shareholder and is anticipated to exhibit a CAGR of 8.44% during the forecast period. The North American urology care devices and platforms market significantly contributes to the global market. The incidences of urological disorders, such as those affecting the excretory and male reproductive systems, are constantly rising in the region. According to GHDx, the prevalence of chronic kidney disease (CKD) in North America is continuously increasing. The numbers increased from 43.2 million in 2018 to 43.9 million in 2019. In addition, technological advancements in the U.S. are driving the remote patient monitoring segment. With the shifting preference from at-clinic to at-home diagnostic and monitoring services, there is a growing demand for remote patient monitoring devices and applications. The data of physiological vitals generated by the device are then analyzed by a physician enabling further diagnosis, treatment, and monitoring of the patient. Furthermore, companies such as I-O Urology and CareLogiQ Corp are also propelling the adoption of remote patient monitoring in the region's market.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Urology Care Devices and Platforms Market Trends

Europe is estimated to exhibit a CAGR of 8.64% over the forecast period. One of the key factors driving the growth of the Europe urology care devices and platforms market is the presence of numerous regional companies. Dornier MedTech GmbH, B. Braun Melsungen AG, and Medtronic plc are local to the region and have a strong presence in the regional and global market. These companies manufacture conventional and advanced urology devices and have furthered technology integration and growth of the Europe market. In addition, the rising prevalence of kidney diseases and diabetes in the region is one of the primary drivers for the growth of the Europe market. According to Global Health Data Exchange, the prevalence of chronic kidney disease (CKD) in the region increased by 13.68% from 2010 to 2019. Furthermore, the prevalence of diabetes increased by 23.13% in the same period. The rising prevalence of the diseases has led to increased adoption of urology care devices and platforms, consequently propelling the market's growth.

The Asia-Pacific urology care devices and platforms market is estimated to be the fastest-growing market over the forecast period. The Asia-Pacific region comprises various global and local companies operating in the region's urological care devices and platforms market. Companies such as Olympus Corporation, Medispec, Fujifilm Holdings Corporation, Nikkiso Co., Ltd., and Polymedicure are local to the region and have a considerable presence in the market. Furthermore, Chinese manufacturers offering economical alternatives and inexpensive raw materials would also advance the growth of the Asia-Pacific market.

Latin America is one of the emerging regional markets in the global market. The marker needs to be improved by the limited number of healthcare personnel in the region which can be attributed to factors such as the shortage of healthcare training centers, barriers preventing citizens from migrating to other regions, and lack of allocation of resources to the healthcare sector of the region. However, expanding healthcare training centers and educational government incentives to promote the urology field hold market growth opportunities.

The incidence of urological disorders, such as those affecting the excretory and male reproductive systems, are constantly rising in the Middle East and Africa.

• For instance, according to GHDx, in 2019, there were 49.7 million and 35.1 million patients with CKD and diabetes in the Middle East and Africa, respectively. This increase in the prevalence of urological disorders boosts market growth. The key drivers for the market include the rising prevalence of urological disorders and improving healthcare infrastructure. However, the market is restrained by various factors, such as the need for more trained medical staff and awareness about the advanced devices and platforms used to diagnose, treat, and monitor urological disorders.

List of Key and Emerging Players in Urology Care Devices and Platforms Market